Topotecan Hydrochloride 45963-0615-56

Package NDC

45963-0615-56

Manufacturer: Actavis Pharma, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 5, 2015
Listing Expires: December 31, 2026
Application: ANDA090620

Need to source Topotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Topotecan Hydrochloride	4 mg/4mL

Drug Class

Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]

Selected Package

45963-0615-56Selected

1 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL